Latest news
At Branding Science, we are more than just consultants; we are your guides leading you across the landscape of the pharmaceutical world. Take a look at our latest news below.
Brand building: pharma’s billion-dollar blind spot
15 seconds That’s all you have, everyday as a marketer. 15 seconds is the maximum amount of time a cognitively overloaded HCP will spend considering prescribing your brand in a live situation. That makes those 15 seconds everything to pharma marketing teams – and to...
The invisible struggle of mental health in Asia: cultural barriers and evolving approaches
Mental health is increasingly coming to the forefront of public discourse around the world, yet in many parts of Asia, it remains a largely invisible struggle. Deeply rooted cultural beliefs, societal stigma and traditional approaches continue to shape how mental...
Take the pain out of brand planning
Brand planning season is upon us, and for many teams, it can feel like an overwhelming process filled with complex templates, endless revisions, and cross-functional challenges. However, brand planning doesn’t have to be painful. By focusing on ambition,...
Why health inequities matter in rare disease and how to bridge the gaps
Health disparities have a significant impact on healthcare systems and are expected to worsen in the coming decades. In the US alone, these disparities already cost the healthcare system $320 billion annually, with projections to reach $1 trillion by 2040. ...
Five key steps to the successful creation and activation of HCP segments
As the time HCPs spend with patients is short, much of their prescribing is habitual. A lot of brands are fighting for their attention, and changing habits is hard. If you want to drive a change to prescribing, your brand’s communications must be ‘spot on’ in terms of...
A breath of fresh air: how pharma is embracing a greener future
The pharmaceutical industry has a powerful remedy for nearly every condition—but what about healing its own carbon footprint? While pharma has been a hero for global health, it’s also left a bit of an environmental mark. In fact, the healthcare industry is responsible...
How Successful Pharma and Biotech Launches Put the Patient Lens at the Center of Brand Strategy
A positive patient experience is the ultimate goal in healthcare, and leading pharma and biotech companies are increasingly focusing on patient-centricity as a core aspect of brand strategy. By viewing the patient as a whole—considering their physical, emotional, and...
Are decentralised trials the solution to our clinical trial woes?
From participant recruitment and retention to ensuring diversity and minimising patient burden, the world of clinical trials faces a unique set of challenges. Decentralised clinical trials (DCTs) have emerged as a potential solution, promising to address some of...
Why brands matter in pharma
Where have all the pharma brands gone? Brands are all around us and shape our decisions in ways we are not conscious of. So why has there been a steady decline in their creation in pharma? Having embraced the idea of brand building in the 2000s/2010s, there has been a...
If AI will make treatment decisions in the future, what does this mean for clinical trial design now?
Our healthcare world is full of examples for how AI could be - or is already - improving diagnosis, treatment, follow up and the overall patient experience. So, what if AI algorithms were used to make recommendations for treatment decisions, to support doctors in...